Gene Editing Technologies Market by Offering (Reagents & Consumables, Services, Software & Systems), Technology (Antisense, CRISPR, Talen), Application, End User - Global Forecast 2024-2030

Gene Editing Technologies Market by Offering (Reagents & Consumables, Services, Software & Systems), Technology (Antisense, CRISPR, Talen), Application, End User - Global Forecast 2024-2030


The Gene Editing Technologies Market size was estimated at USD 5.12 billion in 2023 and expected to reach USD 5.73 billion in 2024, at a CAGR 12.57% to reach USD 11.74 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Gene Editing Technologies Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Gene Editing Technologies Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Gene Editing Technologies Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., AMS Biotechnology Ltd., Beam Therapeutics Inc., Caribou Biosciences, Inc., Cellectis SA, Creative Biogene, CRISPR Therapeutics AG, Editas Medicine, Inc., GenScript Biotech Corporation, Horizon Discovery Ltd., Inscripta, Inc., Integrated DNA Technologies, Inc., Intellia Therapeutics, Inc., Lonza Group Ltd., Mammoth Biosciences, Inc., Merck Group, New England Biolabs, Inc., OriGene Technologies, Inc., Precision BioSciences, Inc., Sangamo Therapeutics, Inc., Synthego Corporation, Takara Bio Inc., Tecan Trading AG, and Thermo Fisher Scientific, Inc..

Market Segmentation & Coverage



This research report categorizes the Gene Editing Technologies Market to forecast the revenues and analyze trends in each of the following sub-markets:

Offering
Reagents & Consumables
Services
Software & Systems
Technology
Antisense
CRISPR
Talen
Zinc Finger Nucleases (ZFN)
Application
Animal Genetic Engineering
Cell Line Engineering
Genetic Engineering
Plant Genetic Engineering
End User
Academic & Government Research Institutes
Biotechnology & Pharmaceutical Companies
Contract Research Organizations
Region
Americas
Argentina

Brazil

Canada

Mexico

United States
California

Florida

Illinois

New York

Ohio

Pennsylvania

Texas
Asia-Pacific
Australia

China

India

Indonesia

Japan

Malaysia

Philippines

Singapore

South Korea

Taiwan

Thailand

Vietnam
Europe, Middle East & Africa
Denmark

Egypt

Finland

France

Germany

Israel

Italy

Netherlands

Nigeria

Norway

Poland

Qatar

Russia

Saudi Arabia

South Africa

Spain

Sweden

Switzerland

Turkey

United Arab Emirates

United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Gene Editing Technologies Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Gene Editing Technologies Market?
3. What are the technology trends and regulatory frameworks in the Gene Editing Technologies Market?
4. What is the market share of the leading vendors in the Gene Editing Technologies Market?
5. Which modes and strategic moves are suitable for entering the Gene Editing Technologies Market?

Note: PDF & Excel + Online Access - 1 Year


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Gene Editing Technologies Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of genetic disorders worldwide
5.1.1.2. Increasing investments for R&D in gene editing
5.1.1.3. Significant improvements in CRISPR-based tools
5.1.2. Restraints
5.1.2.1. High cost of development of gene editing technologies
5.1.3. Opportunities
5.1.3.1. Technological advancements in gene editing technologies
5.1.3.2. Inclination toward personalized medicine approach
5.1.4. Challenges
5.1.4.1. Ethical concerns and stringent regulatory framework
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Gene Editing Technologies Market, by Offering
6.1. Introduction
6.2. Reagents & Consumables
6.3. Services
6.4. Software & Systems
7. Gene Editing Technologies Market, by Technology
7.1. Introduction
7.2. Antisense
7.3. CRISPR
7.4. Talen
7.5. Zinc Finger Nucleases (ZFN)
8. Gene Editing Technologies Market, by Application
8.1. Introduction
8.2. Animal Genetic Engineering
8.3. Cell Line Engineering
8.4. Genetic Engineering
8.5. Plant Genetic Engineering
9. Gene Editing Technologies Market, by End User
9.1. Introduction
9.2. Academic & Government Research Institutes
9.3. Biotechnology & Pharmaceutical Companies
9.4. Contract Research Organizations
10. Americas Gene Editing Technologies Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Gene Editing Technologies Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Gene Editing Technologies Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. Agilent Technologies, Inc.
14.1.2. AMS Biotechnology Ltd.
14.1.3. Beam Therapeutics Inc.
14.1.4. Caribou Biosciences, Inc.
14.1.5. Cellectis SA
14.1.6. Creative Biogene
14.1.7. CRISPR Therapeutics AG
14.1.8. Editas Medicine, Inc.
14.1.9. GenScript Biotech Corporation
14.1.10. Horizon Discovery Ltd.
14.1.11. Inscripta, Inc.
14.1.12. Integrated DNA Technologies, Inc.
14.1.13. Intellia Therapeutics, Inc.
14.1.14. Lonza Group Ltd.
14.1.15. Mammoth Biosciences, Inc.
14.1.16. Merck Group
14.1.17. New England Biolabs, Inc.
14.1.18. OriGene Technologies, Inc.
14.1.19. Precision BioSciences, Inc.
14.1.20. Sangamo Therapeutics, Inc.
14.1.21. Synthego Corporation
14.1.22. Takara Bio Inc.
14.1.23. Tecan Trading AG
14.1.24. Thermo Fisher Scientific, Inc.
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
FIGURE 1. GENE EDITING TECHNOLOGIES MARKET RESEARCH PROCESS
FIGURE 2. GENE EDITING TECHNOLOGIES MARKET SIZE, 2023 VS 2030
FIGURE 3. GENE EDITING TECHNOLOGIES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GENE EDITING TECHNOLOGIES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GENE EDITING TECHNOLOGIES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GENE EDITING TECHNOLOGIES MARKET DYNAMICS
FIGURE 7. GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2023 VS 2030 (%)
FIGURE 8. GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 10. GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 12. GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 14. GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC GENE EDITING TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC GENE EDITING TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. GENE EDITING TECHNOLOGIES MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. GENE EDITING TECHNOLOGIES MARKET SHARE, BY KEY PLAYER, 2023

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings